{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:45:36Z","timestamp":1761518736442},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,1,13]],"date-time":"2004-01-13T00:00:00Z","timestamp":1073952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1038\/sj.ijo.0802574","type":"journal-article","created":{"date-parts":[[2004,1,15]],"date-time":"2004-01-15T11:04:33Z","timestamp":1074164673000},"page":"378-383","source":"Crossref","is-referenced-by-count":16,"title":["Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study"],"prefix":"10.1038","volume":"28","author":[{"given":"H O","family":"Ersoz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ukinc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Baykan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Erem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Durmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Hacihasanoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Telatar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,1,13]]},"reference":[{"key":"BF0802574_CR1","first-page":"63","volume":"20","author":"RP Troiano","year":"1996","unstructured":"Troiano RP, Frongillo EA, Sobal J, Levitsky DA . The relationship between body weight and mortality: a quantitative analysis of combined information from existing studies. Int Obes Relat Metab Disord 1996; 20: 63\u201375.","journal-title":"Int Obes Relat Metab Disord"},{"issue":"1","key":"BF0802574_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2165\/00019053-199400051-00013","volume":"5","author":"IM Baird","year":"1994","unstructured":"Baird IM . Obesity and insurance risk: the insurance industry's viewpoint. PharmacoEconom Suppl 1994; 5 (1): 62\u201365.","journal-title":"PharmacoEconom Suppl"},{"key":"BF0802574_CR3","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1001\/jama.1993.03510180077038","volume":"270","author":"JM McGinnis","year":"1993","unstructured":"McGinnis JM, Foege WH . Actual causes of death in United States. JAMA 1993; 270: 2207\u20132212.","journal-title":"JAMA"},{"key":"BF0802574_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.ijo.0800541","volume":"22","author":"KM Flegal","year":"1998","unstructured":"Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL . Overweight and obesity in the United States: prevalence and trends, 1960\u20131994. Int J Obes Relat Metab Disord 1998; 22: 39\u201347.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0802574_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/j.1550-8528.1996.tb00544.x","volume":"4","author":"GA Bray","year":"1996","unstructured":"Bray GA, Ryan DH, Gordon D . A double blind randomized placebo controlled trial of Sibutramin. Obes Res 1996; 4: 263\u2013270.","journal-title":"Obes Res"},{"issue":"4","key":"BF0802574_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/sj.ijo.0801481","volume":"25","author":"D Hansen","year":"2001","unstructured":"Hansen D, Astrup A, Toubro S, Finer N, Kopelman P, Hilsted J, Rossner S, Saris W, VanGaal L, James W . Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance. Int J Obes Relat Metab Disord 2001; 25 (4): 496\u2013501.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF0802574_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","volume":"7","author":"GA Bray","year":"1999","unstructured":"Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB . Sibutramine produces dose-related weight loss. Obes Res 1999; 7: 189\u2013198.","journal-title":"Obes Res"},{"key":"BF0802574_CR8","doi-asserted-by":"crossref","unstructured":"Hypertension Prevention Trial Research Group. The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Arch Intern Med 1990; 150: 153\u2013162.","DOI":"10.1001\/archinte.1990.00390130131021"},{"key":"BF0802574_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/archinte.1993.00410070039006","volume":"153","author":"VJ Stevens","year":"1993","unstructured":"Stevens VJ, Corrigan SA, Obarzanek E, Bernauer E, Cook NR, Hebert P, Mattfeldt-Beman M, Oberman A, Sugars C, Dalcin AT . Weight loss intervention in phase 1 of the trials of hypertension prevention. The TOHP Collaborative Research Group. Arch Intern Med 1993; 153: 849\u2013858.","journal-title":"Arch Intern Med"},{"key":"BF0802574_CR10","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1001\/archinte.160.14.2185","volume":"160","author":"FG McMahon","year":"2000","unstructured":"McMahon FG, Fujioka K, Singh BN, Mendel CM, Rowe E, Rolston K, Johnson F, Mooradian AD . Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial. Arch Intern Med 2000; 160: 2185\u20132191.","journal-title":"Arch Intern Med"},{"issue":"3","key":"BF0802574_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000047310","volume":"94","author":"BP Hazenberg","year":"2000","unstructured":"Hazenberg BP . Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients. Cardiology 2000; 94 (3): 152\u2013158.","journal-title":"Cardiology"},{"key":"BF0802574_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0002-9343(98)00411-2","volume":"106","author":"M Apfelbaum","year":"1999","unstructured":"Apfelbaum M, Vague P, Ziegler O, Hanotin C, Thomas F, Leutenegger E . Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine. Am J Med 1999; 106: 179\u2013184.","journal-title":"Am J Med"},{"key":"BF0802574_CR13","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","volume":"356","author":"WP James","year":"2000","unstructured":"James WP, Astrup A, Finer N, Hilsted J, Kopelman P, Rossner S, Saris WH, Van Gaal LF . Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119\u20132125.","journal-title":"Lancet"},{"key":"BF0802574_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1079\/BJN2002612","volume":"88","author":"AM Swartz","year":"2002","unstructured":"Swartz AM, Jeremy Evans M, King GA, Thompson DL . Evaluation of a foot-to-foot bioelectrical impedance analyzer in highly active, moderately active and less active young men. Br J Nutr 2002; 88: 205\u2013210.","journal-title":"Br J Nutr"},{"key":"BF0802574_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1017\/S0007114500000155","volume":"83","author":"SA Jebb","year":"2000","unstructured":"Jebb SA, Cole TJ, Doman D, Mugratroyd PR, Prentice AP . Evaluation of the novel Tanita body fat analyzer to measure body composition by comparison with four-compartment model. Br J Nutr 2000; 83: 115\u2013122.","journal-title":"Br J Nutr"},{"key":"BF0802574_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Mathews","year":"1985","unstructured":"Mathews DR, Hosker JP, Rudensky A, Turner RC . Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 401\u2013411.","journal-title":"Diabetologia"},{"key":"BF0802574_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/eurheartj\/8.suppl_B.57","volume":"8\/B","author":"S MacMahon","year":"1987","unstructured":"MacMahon S, Cutler J, Brittain E, Higgins M . Obesity and hypertension: epidemiological and clinical issues. Eur Heart J Suppl 1987; 8\/B: 57\u201370.","journal-title":"Eur Heart J Suppl"},{"key":"BF0802574_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/1047-2797(91)90046-F","volume":"1","author":"JA Cutler","year":"1991","unstructured":"Cutler JA . Randomized clinical trials of weight reduction in nonhypertensive persons. Ann Epidemiol 1991; 1: 363\u2013370.","journal-title":"Ann Epidemiol"},{"key":"BF0802574_CR19","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S . Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomized trial. Lancet 1998; 351: 1755\u20131762.","journal-title":"Lancet"},{"key":"BF0802574_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/01.HYP.14.5.570","volume":"14","author":"J Stamler","year":"1989","unstructured":"Stamler J . INTERSALT study findings. Public health and medical care implications. Hypertension 1989; 14: 570\u2013577.","journal-title":"Hypertension"},{"key":"BF0802574_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/oby.2000.26","volume":"8","author":"J Hirsch","year":"2000","unstructured":"Hirsch J, Mackintosh RM, Aronne LJ . The effects of drugs used to treat obesity on the autonomic nervous system. Obes Res 2000; 8: 227\u2013233.","journal-title":"Obes Res"},{"key":"BF0802574_CR22","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1161\/01.CIR.0000036370.31856.73","volume":"106","author":"AL Birkenfeld","year":"2002","unstructured":"Birkenfeld AL, Schroeder C, Boschmann M, Tank J, Franke G, Luft FC, Biaggioni I, Sharma AM, Jordan J . Paradoxical effect of sibutramine on autonomic cardiovascular regulation. Circulation 2002; 106: 2459\u20132465.","journal-title":"Circulation"},{"key":"BF0802574_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1161\/01.HYP.37.2.250","volume":"37","author":"AM Sharma","year":"2001","unstructured":"Sharma AM, Pischon T, Hardt S, Kunz I, Luft FC . Hypothesis: beta-adrenergic receptor blockers and weight gain: a systematic analysis. Hypertension 2001; 37: 250\u2013254.","journal-title":"Hypertension"},{"key":"BF0802574_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1152\/physrev.1999.79.2.451","volume":"79","author":"E Jequier","year":"1996","unstructured":"Jequier E, Tappy L . Regulation of body weight in humans. Physiol Rev 1996; 79: 451\u2013480.","journal-title":"Physiol Rev"},{"key":"BF0802574_CR25","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/sj.bjp.0701311","volume":"121","author":"HC Jackson","year":"1997","unstructured":"Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ . Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat. Br J Pharmacol 1997; 121: 1613\u20131618.","journal-title":"Br J Pharmacol"},{"key":"BF0802574_CR26","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/sj.bjp.0702446","volume":"126","author":"IP Connoley","year":"1999","unstructured":"Connoley IP, Liu YL, Frost I, Reckless IP, Heal DJ, Stock MJ . Thermogenic effects of sibutramine and its metabolites. Br J Pharmacol 1999; 126: 1487\u20131495.","journal-title":"Br J Pharmacol"},{"key":"BF0802574_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/sj.jhh.1001299","volume":"16","author":"JJ Sramek","year":"2002","unstructured":"Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR . Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by adrenergic blocking agents: a placebo controlled double-blind, randomized trial. J Hum Hypertens 2002; 16: 13\u201319.","journal-title":"J Hum Hypertens"},{"key":"BF0802574_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/oby.2000.10","volume":"8","author":"GEM Cuellar","year":"2000","unstructured":"Cuellar GEM, Ruiz AM, Monsalve MCR, Berber A . Six month treatment of obesity with sibutramine 15\u2009mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population. Obes Res 2000; 8: 71\u201382.","journal-title":"Obes Res"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/0802574.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0802574","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/0802574.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T07:29:38Z","timestamp":1684222178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/0802574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,13]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["BF0802574"],"URL":"https:\/\/doi.org\/10.1038\/sj.ijo.0802574","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,13]]}}}